$INTI

$0.07 -$0.01 (16.74%) Close

$INTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 173.8M shares outstanding

Inhibitor Therapeutics Inc is not yet matched to a CUSIP, so institutional (13F) holdings cannot be attributed to it. The sections below that come from its own filings still apply.

Who owns INTI?

By type of holder

Institutions 0.0% Insiders 100.0% Everyone else 0.0%

Concentration Top 6 holders own 67.1%

Mcnulty James A 40.8% · Odonnell Francis E JR 24.7%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Inhibitor Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+0.3%

+0.16% a year

Each share's claim on the business

−0.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $77.4K

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding INTI.

Super Investors

Investment managers reporting INTI on Form 13F

No 13F manager reports holding INTI yet.

Institutional Funds

Mutual funds and ETFs reporting INTI on Form N-PORT; together they hold 0.0% of the company

No fund reports holding INTI yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MJ Mcnulty James A Insider	70.9M	40.77%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company40.770% Mcnulty James A's insider activity →
OF Odonnell Francis E JR Insider	43.0M	24.72%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company24.720% Odonnell Francis E JR's insider activity →

Mcnulty James A

Insider

70.9M

% of company

40.77%

Change vs last qtr

—

Held since

—

Odonnell Francis E JR

Insider

43.0M

% of company

24.72%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Inhibitor Therapeutics Inc.

Comments